PPARG and fatty liver disease: Genistein also attenuated hepatic steatosis by reducing the PPARγ target gene monoacylglycerol O-acyltransferase 1, mRNA level in apolipoprotein E-deficient (ApoE(−/−)) mice fed a HF diet [12].